Scientific consulting firm Exponent (NASDAQ:EXPO) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 19.1% year on year to $147.4 million. Its GAAP profit of $0.49 per share was 3.7% above analysts’ consensus estimates.

Medical professional network Doximity (NYSE:DOCS) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.8% year on year to $185.1 million. On the other hand, next quarter’s revenue guidance of $143.5 million was less impre

Semiconductor designer Power Integrations (NASDAQ:POWI) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 1.9% year on year to $103.2 million. The company expects next quarter’s revenue to be around $106.5 million, close to analysts’

Global media and publishing company News Corp (NASDAQ:NWSA) announced better-than-expected revenue in Q4 CY2025, with sales up 5.5% year on year to $2.36 billion. Its GAAP profit of $0.34 per share was in line with analysts’ consensus estimates.

There’s been no single cause, like there was last April when President Donald Trump’s trade war sent markets into a fearful tailspin. Instead, it’s been a slow drumbeat of news that is sowing anxiety about valuations that many suspected had already run u

Cloud computing and online retail behemoth Amazon (NASDAQ:AMZN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 13.6% year on year to $213.4 billion. The company expects next quarter’s revenue to be around $176 billion, close to analys

Performance marketing company QuinStreet (NASDAQ:QNST) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 1.9% year on year to $287.8 million. On top of that, next quarter’s revenue guidance ($335 million at the midpoint)

Cybersecurity cloud platform provider Qualys (NASDAQ:QLYS) announced better-than-expected revenue in Q4 CY2025, with sales up 10.1% year on year to $175.3 million. The company expects next quarter’s revenue to be around $173.5 million, close to analysts’

Collaboration software company Atlassian (NASDAQ:TEAM) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 23.3% year on year to $1.59 billion. Guidance for next quarter’s revenue was optimistic at $1.69 billion at the mid

Freight delivery company Werner (NASDAQ:WERN) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 2.3% year on year to $737.6 million. Its non-GAAP profit of $0.05 per share was 52.3% below analysts’ consensus estimates.

Global music entertainment company Warner Music Group (NASDAQ:WMG) announced better-than-expected revenue in Q4 CY2025, with sales up 10.4% year on year to $1.84 billion. Its GAAP profit of $0.33 per share was 7% below analysts’ consensus estimates.

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.55 billion at the midpoint came in 3.1% above analysts’ estimates.

Hims & Hers Health, Eli Lilly, and Novo Nordisk shares all slid Thursday after Hims & Hers said it would start selling a compounded weight-loss pill, at a lower price than rivals.

Semiconductor production equipment provider Amtech Systems (NASDAQ:ASYS) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 22.2% year on year to $18.97 million. The company expects next quarter’s revenue to be around $20 million, comi

Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 22.4% year on year to $13.25 million. Its non-GAAP loss of $0.29 per share was 13.9% above analysts’